1. Home
  2. ATNM vs CMTL Comparison

ATNM vs CMTL Comparison

Compare ATNM & CMTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.11

Market Cap

36.8M

Sector

Health Care

ML Signal

HOLD

Logo Comtech Telecommunications Corp.

CMTL

Comtech Telecommunications Corp.

HOLD

Current Price

$4.90

Market Cap

162.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATNM
CMTL
Founded
2000
1967
Country
United States
United States
Employees
N/A
1385
Industry
Biotechnology: Pharmaceutical Preparations
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
36.8M
162.1M
IPO Year
2013
2024

Fundamental Metrics

Financial Performance
Metric
ATNM
CMTL
Price
$1.11
$4.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$4.00
$6.00
AVG Volume (30 Days)
107.1K
224.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
30.60
N/A
EPS
N/A
N/A
Revenue
$81,000.00
$499,528,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$1.19
52 Week High
$1.95
$6.21

Technical Indicators

Market Signals
Indicator
ATNM
CMTL
Relative Strength Index (RSI) 43.06 42.20
Support Level $1.02 $4.86
Resistance Level $1.25 $5.50
Average True Range (ATR) 0.07 0.36
MACD 0.00 -0.06
Stochastic Oscillator 27.03 20.62

Price Performance

Historical Comparison
ATNM
CMTL

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About CMTL Comtech Telecommunications Corp.

Comtech Telecommunications Corp is a provider of communications technology and solutions. It operates in two reportable business segments: Satellite and Space Communications and Allerium. The company's Satellite and Space Communications segment, which generates maximum revenue, is organized into four technology areas: satellite modem and amplifier technologies, troposcatter technologies, cybersecurity training, and space components. This segment designs and manufactures modems, amplifiers, traveling wave tube amplifiers, frequency converters, and offers other associated software and services. The Allerium segment provides next-generation 911 (NG-911) infrastructure and solutions for state and local governments and carriers. Geographically, the company derives its key revenue from the USA.

Share on Social Networks: